DJ Amgen Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Amgen Inc. $(AMGN)$ slipped 1.30% to $292.62 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.01% to 6,449.15 and Dow Jones Industrial Average falling 0.08% to 44,911.82.
The stock's fall snapped a three-day winning streak.
Amgen Inc. closed 13.72% short of its 52-week high of $339.17, which the company achieved on September 23rd.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 0.22% to $176.25, Pfizer Inc. $(PFE)$ fell 0.28% to $25.07, and AbbVie Inc. $(ABBV)$ fell 0.06% to $206.57.
Trading volume (1.7 M) remained 624,984 below its 50-day average volume of 2.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 18, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
August 18, 2025 16:35 ET (20:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.